Pluto Pets launches AI-driven longevity platform for dogs in New York City

Pluto Pets unveiled an AI-powered pet longevity platform on Nov. 21, 2025, positioning its PlutoOS system as a 24/7 health co‑pilot that turns clinical records into personalized, predictive care plans for dogs.

A healthy adult mixed-breed dog next to a laptop showing the PlutoOS dashboard in a veterinary clinic

Pluto Pets Launches the First AI-Powered Pet Longevity Platform, a science-driven startup, publicly launched an AI-powered pet longevity platform in New York City on Nov. 21, 2025, positioning the system as a continuous health assistant for dog owners.

The platform, presented in launch materials distributed via Newswire and handled by Sarah McDonald, Head of PR at Pluto Pets, uses clinical data, owner-reported information and lifestyle details to build individualized health plans for dogs under a system the company calls PlutoOS. Pluto Pets described the product as a 24/7 “Health Co‑Pilot” intended to predict risks early and provide clear, actionable next steps.

Company materials say PlutoOS converts more than 12 million clinical data points into personalized recommendations. Users can upload veterinary records and report symptoms and daily habits; the platform then synthesizes that information into predictive guidance that the company frames as both preventative and actionable, rather than episodic advice tied only to clinic visits.

“Most owners only discover problems when it’s already an emergency. Pluto flips the script – it predicts risks early, explains everything simply, and tells you exactly what to do next so your dog lives longer, happier, and crisis-free,” said the Founder & CEO of Pluto Pets in a statement accompanying the launch. The company described the rollout as its public debut for the platform in New York City.

The launch comes amid growing use of consumer technology in pet care: Pluto Pets cited research indicating that a significant portion of U.S. dog owners use GPS-enabled collars or tracking devices, with particular adoption among younger owners. Younger owners — particularly Gen Z — already use multiple pet health tools, averaging roughly 3.6 different devices or services and showing strong interest in symptom checkers and digital health features.

Pluto Pets emphasized personalization as central to the platform. Rather than offering one-size-fits-all guidance, PlutoOS maps a dog’s full medical history, current symptoms and daily environment into tailored plans meant to monitor chronic conditions and flag emerging issues before they escalate. The company characterized those recommendations as step-by-step actions owners can take or discuss with their veterinarian.

The choice to focus on longevity reflects common health challenges in aging dogs: the company cited that the most frequent issues include osteoarthritis, kidney disease, cancer, cognitive dysfunction and dementia, diabetes, blindness and dental disease. Pluto Pets positioned PlutoOS as a tool to help owners and clinicians prioritize monitoring and intervention for those types of conditions.

Pluto Pets also framed the launch in the context of how AI is being applied across health care. The company noted that AI in pet health faces unique hurdles compared with human medicine, chiefly because veterinary data collection is less standardized and there is currently less regulatory oversight of veterinary AI tools than in human healthcare, where organizations such as CloudLIMS and HealthforAnimals have helped shape frameworks. While both fields deploy AI for predictive analytics and decision support, veterinary applications lack the same data standardization and regulatory pathways, the company said.

At launch, Pluto Pets described the platform as its first AI-powered pet longevity offering. The company made detailed product information and statements available on Nov. 21, 2025, and said it would continue to refine models and recommendations as more clinical records and user-reported data are integrated into PlutoOS.

Pluto Pets did not disclose pricing or the full regulatory approach for its algorithms in the launch release. The company’s announcement focused on positioning the platform as a continuous companion to veterinary care — a tool designed to catch risks earlier and guide owners through next steps — rather than replacing clinical judgment or in-person care.

Source

Original reporting: view the original article.

Comments are closed.